NCT01048723View on ClinicalTrials.gov

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Sarcoma

Interventions

DRUG

RAD001

Patients were instructed to take RAD001 in the morning, at the same time each day.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER